Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renexin CR vs Aspirin in Diabetic Peripheral Angiopathy
NCT05906199Phase 4Completed
- Sponsor
- SK Chemicals
- Start
- Jul 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol + ginkgo leaf extract in diabetic peripheral angiopathy (DPA), sponsored by SK Chemicals. Started Jul 2021; status: completed.
02
Drugs
cilostazol + ginkgo leaf extract
03
Conditions
diabetic peripheral angiopathy (DPA)
Beyond the preview
Go deeper on NCT05906199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05906199.